Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model

Femke Heindryckx; Eliene Bogaerts; Stéphanie Coulon; Hilde Devlies; Anja Geerts; Louis Libbrecht; Jean Marie Stassen; Peter Carmeliet; Isabelle Colle; Hans Van Vlierberghe

doi:10.1097/meg.0b013e3283554219

Related publications

Article2010

Effect of PlGF-inhibition on survival in mice with hepatocellular carcinoma

Femke Heindryckx, Anja Geerts, Peter Carmeliet, Isabelle Colle, Hans Van Vlierberghe

Article2011

Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice

Christophe Van Steenkiste, Jordi Ribera, Anja Geerts, Montse Pauta, Sònia Tugues, Christophe Casteleyn, Louis Libbrecht, Kim Olievier, Ben Schroyen, Hendrik Reynaert, Leo A. van Grunsven, Bram Blomme, Stéphanie Coulon, Femke Heindryckx, Martine De Vos, Jean Marie Stassen, Stefan Vinckier, José Altamirano, Ramón Bataller, Peter Carmeliet, Hans Van Vlierberghe, Isabelle Colle, Manuel Morales‐Ruiz

Article2010

Inhibition of PlGF as a potential therapy against hepatocellular carcinoma

Femke Heindryckx, Lara Crapé, G Cornelis, Peter Carmeliet, Isabelle Colle, Hans Van Vlierberghe

Article2017

Additional file 2: Figure S1. of Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma

Yves‐Paul Vandewynckel, Debby Laukens, Lindsey Devisscher, Eliene Bogaerts, Annelies Paridaens, Anja Van den Bussche, Sarah Raevens, Xavier Verhelst, Christophe Van Steenkiste, Bart Jonckx, Louis Libbrecht, Anja Geerts, Peter Carmeliet, Hans Van Vlierberghe

Article2010

Abstract LB-363: Inhibition of placental growth factor (PlGF) leads to regression of medulloblastoma

Matija Snuderl, Nathaniel D. Kirkpatrick, Elisa C. Walsh, Euiheon Chung, Walid S. Kamoun, Teresa Peterson, Lance L. Munn, Dan G. Duda, Dai Fukumura, Peter Carmeliet, Lei Xu, Rakesh K. Jain

Inhibition of the placental growth factor decreases burden of cholangiocarcinoma and hepatocellular carcinoma in a transgenic mouse model

Abstract

Discussion(0)

Related publications

Effect of PlGF-inhibition on survival in mice with hepatocellular carcinoma

Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice

Inhibition of PlGF as a potential therapy against hepatocellular carcinoma

Additional file 2: Figure S1. of Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma

Abstract LB-363: Inhibition of placental growth factor (PlGF) leads to regression of medulloblastoma